Skip to Content

Lazard International Equity Advtg Instl IEAIX

Medalist Rating as of | See Lazard Investment Hub
  • NAV / 1-Day Return 11.83  /  +0.09 %
  • Total Assets 20.5 Mil
  • Adj. Expense Ratio
    0.800%
  • Expense Ratio 0.800%
  • Distribution Fee Level Average
  • Share Class Type Institutional
  • Category Foreign Large Blend
  • Investment Style Large Blend
  • Min. Initial Investment 10,000
  • Status Open
  • TTM Yield 0.58%
  • Turnover 88%

USD | NAV as of Apr 26, 2024 | 1-Day Return as of Apr 26, 2024, 10:14 PM GMT+0

Morningstar’s Analysis IEAIX

Will IEAIX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Lazard International Equity Advtg Instl’s management team is rated Average, but a solid investment process still helps this strategy retain its Morningstar Medalist Rating of Bronze.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The portfolio maintains a sizable cost advantage over competitors, priced within the second-cheapest fee quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings IEAIX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 20.8
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Novo Nordisk A/S Class B

3.21 669,685
Healthcare

ASML Holding NV

2.75 574,130
Technology

GSK PLC

2.29 477,647
Healthcare

State Bank of India DR

2.04 425,111
Financial Services

Manulife Financial Corp

1.80 374,951
Financial Services

Constellation Software Inc

1.78 371,489
Technology

Vinci SA

1.74 364,026
Industrials

Infineon Technologies AG

1.72 358,247
Technology

ABB Ltd

1.72 358,167
Industrials

Dr Reddy's Laboratories Ltd ADR

1.71 357,361
Healthcare